Niagen Bioscience outlines 10% to 15% 2026 e-commerce growth while positioning Niagen Plus and NB4168 for 2027 traction (NASDAQ:NAGE)
· seekingalpha.com
Niagen Bioscience (NAGE) Q2 2026 earnings call: revenue $29.8M, 10–15% e-commerce growth outlook, NAD Pharma launch and NB4168 updates—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...